Glass Cleaner 500 ml,Room Freshner,Dust Bin with Cover Combined,Plastic Mug,Detergent Powder in 1 K
Indian Coast Guard
NORTH AND MIDDLE ANDAMAN, ANDAMAN & NICOBAR
Bid Publish Date
26-Nov-2024, 7:01 pm
Bid End Date
17-Dec-2024, 7:00 pm
EMD
₹17
Progress
Quantity
16560
A tender has been published for Indian Army Inj Dexmedetomidine 100 mcgml 1 ml vial, Diethyl Ether Solvent Bott of 500 ml, Thiopentone Inj of 0po. Quantity: 16560 by. Submission Deadline: 17-12-2024 19: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Coast Guard
NORTH AND MIDDLE ANDAMAN, ANDAMAN & NICOBAR
Indian Army
DEHRADUN, UTTARAKHAND
Dg Armed Forces Medical Service
BANGALORE, KARNATAKA
Indian Army
PITHORAGARH, UTTARAKHAND
Indian Army
SAGAR, MADHYA PRADESH
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Inj Dexmedetomidine 100 mcgml 1 ml vial | As per title | 60 | amp | vibhu@181 | 21 |
| 2 | Diethyl Ether Solvent Bott of 500 ml | As per title | 60 | bott | vibhu@181 | 21 |
| 3 | Thiopentone Inj of 0point5 g without water for Injection | As per title | 30 | ampvial | vibhu@181 | 21 |
| 4 | Lignocaine HCL 2 percentWithout Adrenaline 30 Ml Suitable for Opthalmic use also | As per title | 90 | ampvial | vibhu@181 | 21 |
| 5 | Inj Etomidate 2 mgml 10 ml Vial | As per title | 12 | vial | vibhu@181 | 21 |
| 6 | Lignocaine HCl 2 percent with Adrenaline 1 estu 80000 30 ml Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 7 | Inj Diclofenac 75 mg ml 1 ml Amp | As per title | 30 | amp | vibhu@181 | 21 |
| 8 | Lignocaine 100 mg Ethanol 28 percent spray container of 500 ml | As per title | 30 | nopoint | vibhu@181 | 21 |
| 9 | Inj Ephedrine Hydrochloride 30 mgml | As per title | 12 | amp | vibhu@181 | 21 |
| 10 | Atropine Sulphate 0 point 6 mg 1 ml Inj | As per title | 480 | ampvial | vibhu@181 | 21 |
| 11 | Inj Pentazocine Lactate 30 mg ml 1 ml Amp | As per title | 6 | amp | vibhu@181 | 21 |
| 12 | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml | As per title | 1,500 | bott | vibhu@181 | 21 |
| 13 | Piroxicam 40 mg 2 ml Inj | As per title | 30 | no | vibhu@181 | 21 |
| 14 | Morphine 15 mg 1 ml Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 15 | Pethedine 50 mg 1 ml Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 16 | Adrenaline Tartrate 1 to 1000 1 ml Inj | As per title | 600 | ampvial | vibhu@181 | 21 |
| 17 | Promethazine hcl 2 point 5 percent 25 mgml 2 ml Inj | As per title | 120 | ampvial | vibhu@181 | 21 |
| 18 | N-Acetyl Cysteine 1 gm 5ml Inj | As per title | 12 | amp | vibhu@181 | 21 |
| 19 | Naloxone Hydrochloride 1 mg 1ml Inj | As per title | 60 | vial | vibhu@181 | 21 |
| 20 | Pralidoxime 500 mg 20 ml Inj | As per title | 180 | nopoint | vibhu@181 | 21 |
| 21 | Levetiracetam 100mg ml Vial of 5 ml inj | As per title | 240 | vial | vibhu@181 | 21 |
| 22 | Inj Fosphenytoin 75mg ml 2 ml amp | As per title | 90 | ampvial | vibhu@181 | 21 |
| 23 | Sodium Valproate 100 mg ml Inj | As per title | 60 | ampvial | vibhu@181 | 21 |
| 24 | Inj Ceftazidime 250 mg Vial | As per title | 90 | vial | vibhu@181 | 21 |
| 25 | Streptomycin 1 g Inj | As per title | 24 | ampvial | vibhu@181 | 21 |
| 26 | Inj Amikacin IP 100 mg2 ml Vial | As per title | 120 | vial | vibhu@181 | 21 |
| 27 | Artesunate 60mg Inj | As per title | 300 | ampvial | vibhu@181 | 21 |
| 28 | Artemether 80 mg ml 1 ml Inj | As per title | 150 | ampvial | vibhu@181 | 21 |
| 29 | Quinine Dihydrochloride 300 mg ml 2 ml Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 30 | Inj Ampicillin Sodium IP 250 mg Vial | As per title | 12 | vial | vibhu@181 | 21 |
| 31 | Inj Ceftazidime 500 mg Vial | As per title | 90 | vial | vibhu@181 | 21 |
| 32 | Inj Benzathine Penicillin 1200000 IU Vial | As per title | 30 | vial | vibhu@181 | 21 |
| 33 | Inj Cefotaxime Sodium 250 mg plus Sulbactam 125 mg Vial | As per title | 60 | vial | vibhu@181 | 21 |
| 34 | Inj Cefotaxime Sodium 500 mg plus Sulbactam 250 mg Inj Vial | As per title | 60 | vial | vibhu@181 | 21 |
| 35 | Anti D 300 mcg Inj Vial of 2 ml | As per title | 12 | vial | vibhu@181 | 21 |
| 36 | Methotrexate Sodium 50mg 2 ml Inj | As per title | 12 | ampvial | vibhu@181 | 21 |
| 37 | Methotrexate 15mg Preservative Free 3 ml Inj | As per title | 12 | ampvial | vibhu@181 | 21 |
| 38 | Ferric hydroxide sucrose complex 20 mg in 5ml for Injection | As per title | 18 | ampvial | vibhu@181 | 21 |
| 39 | Tranexamic Acid 500 mg5ml Inj | As per title | 450 | ampvial | vibhu@181 | 21 |
| 40 | Phytomenadione Vit K1 mg 0point5 ml Inj | As per title | 420 | ampvial | vibhu@181 | 21 |
| 41 | Inj Tenecteplase 20 mg | As per title | 6 | vial | vibhu@181 | 21 |
| 42 | Adenosine 3mgml 2ml Inj | As per title | 120 | ampvial | vibhu@181 | 21 |
| 43 | Adenosine 3 mgml 10 ml Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 44 | Metoprolol 1 mgml 5 ml Inj | As per title | 120 | ampvial | vibhu@181 | 21 |
| 45 | Sodium Nitroprusside 50 mg Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 46 | Digoxin 0point5 mg 2 ml Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 47 | Vasopressin 20 unitsml Inj 1ml Amp | As per title | 90 | amp | vibhu@181 | 21 |
| 48 | Labetalol HCl 5mgml 4ml Inj | As per title | 240 | ampvial | vibhu@181 | 21 |
| 49 | Triamcinolone 40 mgVial Inj | As per title | 30 | no | vibhu@181 | 21 |
| 50 | Triamcinolone Acetate 10 mgml Inj | As per title | 6 | ampvial | vibhu@181 | 21 |
| 51 | Frusemide 20 mg 2 ml Inj | As per title | 480 | ampvial | vibhu@181 | 21 |
| 52 | Octreotide 0 point1 mg ml Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 53 | Polidocanol 3 percent 2ml Inj | As per title | 24 | ampvial | vibhu@181 | 21 |
| 54 | Metoclopramide HCl 5mgml 2ml Inj | As per title | 480 | ampvial | vibhu@181 | 21 |
| 55 | Dicyclomine HCl 20 mg Inj | As per title | 180 | ampvial | vibhu@181 | 21 |
| 56 | Purified FSH 75 IU Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 57 | Carboprost Tromethamine 250 mcgml 1ml Inj | As per title | 120 | ampvial | vibhu@181 | 21 |
| 58 | Hydroxyprogesterone Caproate 500 mg2 ml Amp of 2 mlInj | As per title | 300 | ampvial | vibhu@181 | 21 |
| 59 | Methylergometrine maleate 0 point 2 mg 1 ml Inj | As per title | 180 | ampvial | vibhu@181 | 21 |
| 60 | Oxytocin 5 units per 1 point 0 ml amp Inj | As per title | 900 | ampvial | vibhu@181 | 21 |
| 61 | Magnesium sulphate 50 percent wv Inj | As per title | 420 | ampvial | vibhu@181 | 21 |
| 62 | Neostigmine 0 point 5 mg 1 ml Inj | As per title | 360 | ampvial | vibhu@181 | 21 |
| 63 | Succinylchloline Chloride 50 mg ml 2 ml Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 64 | Vecuronium Bromide 4mgml 1 ml Inj | As per title | 150 | ampvial | vibhu@181 | 21 |
| 65 | Lignocaine 1 percent for intra-ocular use vial of 1 ml preservative free | As per title | 12 | ampvial | vibhu@181 | 21 |
| 66 | Caffeine Citrate 20 mg ml Inj 1ml vial | As per title | 30 | ampvial | vibhu@181 | 21 |
| 67 | Natural Surfactant 25 to 80 mg ml Inj | As per title | 12 | vial | vibhu@181 | 21 |
| 68 | Haloperidol decanoate 50 mgml Inj in 1ml amp | As per title | 30 | amp | vibhu@181 | 21 |
| 69 | Haloperidol 5mgml Inj | As per title | 60 | ampvial | vibhu@181 | 21 |
| 70 | Etophylline BP 84point7 mg and Theophylline IP 25point3 mg per ml 2 ml Inj | As per title | 60 | ampvial | vibhu@181 | 21 |
| 71 | Dextrose 50 percent 25 ml Inj | As per title | 180 | ampvial | vibhu@181 | 21 |
| 72 | Dextrose Inj 25 percent 25 ml Inj | As per title | 240 | ampvial | vibhu@181 | 21 |
| 73 | Sodium Chloride 3 percent Injection Bott of 100 ml | As per title | 120 | bott | vibhu@181 | 21 |
| 74 | Drotaverine HCl 1 percent 20 mgml 2 ml Inj | As per title | 180 | ampvial | vibhu@181 | 21 |
| 75 | Vit B1 50 mg Inj | As per title | 390 | ampvial | vibhu@181 | 21 |
| 76 | Multi Vit Inj IV 2 to 10 ml with Thiamine B1-30 mg ml Pyridoxine B630 mg ml and B12 Cyanocobalamin 300 mcg ml | As per title | 120 | ampvial | vibhu@181 | 21 |
| 77 | Methyl Prednisolone Sodium Succinate 40 mg Inj | As per title | 48 | ampvial | vibhu@181 | 21 |
| 78 | Inj Methotrexate 15 mg 1 ml | As per title | 30 | vial | vibhu@181 | 21 |
| 79 | Ampicillin 500 mg Inj | As per title | 30 | inj | vibhu@181 | 21 |
| 80 | Inj Benzathine penicillin 600000 iu | As per title | 30 | ampvial | vibhu@181 | 21 |
| 81 | Benzyl penicillin 500000 Units Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 82 | Ceftriaxone 1 gm Inj | As per title | 600 | ampvial | vibhu@181 | 21 |
| 83 | Cefuroxime 750 mgVial Inj | As per title | 90 | ampvial | vibhu@181 | 21 |
| 84 | Cefepime 1gm Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
| 85 | Clarithromycin 500mg Inj | As per title | 300 | ampvial | vibhu@181 | 21 |
| 86 | Gentamycin sulphate Inj IM IV 40 mgml 2 ml Inj | As per title | 270 | ampvial | vibhu@181 | 21 |
| 87 | Imipenem 500mg plus Cilastin 500mg Inj | As per title | 120 | ampvial | vibhu@181 | 21 |
| 88 | Ticarcillin 3g plus Clavulanic Acid 100 mg Inj | As per title | 60 | ampvial | vibhu@181 | 21 |
| 89 | Inj Azithromycin 500 mg | As per title | 30 | vial | vibhu@181 | 21 |
| 90 | Inj Amikacin Sulphate 250 mg ml | As per title | 90 | vial | vibhu@181 | 21 |
| 91 | Acyclovir 250 mg Inj | As per title | 150 | ampvial | vibhu@181 | 21 |
| 92 | Inj Nitroglycerine Glyceryltrinitrate 5 mg | As per title | 150 | amp | vibhu@181 | 21 |
| 93 | Inj Thiamine 100 mgml 2 ml Amp | As per title | 600 | amp | vibhu@181 | 21 |
| 94 | Human Chorionic Gonadotropin 5000 IU Inj | As per title | 60 | amp | vibhu@181 | 21 |
| 95 | Human Menopausal Gonadotropin 75 IU Inj | As per title | 60 | vial | vibhu@181 | 21 |
| 96 | Clindamycin 600 mg Injection 150 mg ml of 4 ml | As per title | 90 | vial | vibhu@181 | 21 |
| 97 | BCG Vaccine | As per title | 6 | ampvial | vibhu@181 | 21 |
| 98 | Diphtheria and Tetanus Vaccine PTAP vial of 5 ml | As per title | 6 | ampvial | vibhu@181 | 21 |
| 99 | Hepatitis B Vaccine 10 ml | As per title | 30 | ampvial | vibhu@181 | 21 |
| 100 | Hepatitis B Human Immunoglobulin HBIG200 IU ml | As per title | 12 | ampvial | vibhu@181 | 21 |
| 101 | Typhoid Vi Conjugate Vaccine 0 point 5ml | As per title | 120 | vialpfs | vibhu@181 | 21 |
| 102 | Human Diploid cell rabies vaccine | As per title | 180 | vial | vibhu@181 | 21 |
| 103 | Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0 point 5 ml | As per title | 96 | pfs | vibhu@181 | 21 |
| 104 | Japanese Encephalitis Vaccine | As per title | 96 | vial | vibhu@181 | 21 |
| 105 | Inj Varicella Vaccine live attenuated monovalent containing at least 1000 PFU per 0 point 5 ml | As per title | 96 | ampvial | vibhu@181 | 21 |
| 106 | Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses | As per title | 300 | ampvial | vibhu@181 | 21 |
| 107 | Human Rabies Immune Globulin 150 IU per ml 2 ml | As per title | 60 | vial | vibhu@181 | 21 |
| 108 | Lorazepam 2 mgml 2 ml Inj | As per title | 100 | ampvial | vibhu@181 | 21 |
| 109 | Teicoplanin 200 mg Inj | As per title | 20 | ampvial | vibhu@181 | 21 |
| 110 | Dantrolene Sodium 250 mg per Vial Inj | As per title | 30 | vial | vibhu@181 | 21 |
| 111 | Inj Human chronic Gonadotropin HCG10000 IU | As per title | 30 | vial | vibhu@181 | 21 |
| 112 | Inj Mephenteramine 10ml | As per title | 18 | vial | vibhu@181 | 21 |
| 113 | Inj Multi vitamin infusion amp of 10 ml | As per title | 300 | amp | vibhu@181 | 21 |
| 114 | Inj Ropivacaine hcl in dextrose 0point75 percent Amp of 4 ml | As per title | 12 | amp | vibhu@181 | 21 |
| 115 | Phenylephrine 10 mgml Amp of 1 ml Inj | As per title | 18 | amp | vibhu@181 | 21 |
| 116 | Mumps measles rubella vaccine MMR | As per title | 90 | amp | vibhu@181 | 21 |
| 117 | Live Attenuated HepatitisA Vaccine | As per title | 90 | amp | vibhu@181 | 21 |
| 118 | Oral Vitamin A | As per title | 30 | amp | vibhu@181 | 21 |
| 119 | Diptheria Tetanus and Acellular pertusis DTaPvaccine | As per title | 90 | amp | vibhu@181 | 21 |
| 120 | Inj PPD Tuberculin Purified Protein Derivative 5TU 0 point 1ml | As per title | 30 | vial | vibhu@181 | 21 |
| 121 | Diltiazem 5mg ml Inj | As per title | 30 | ampvial | vibhu@181 | 21 |
Discover companies most likely to bid on this tender
The eligibility requirements stipulate that bidders must be registered entities conforming to relevant income tax and GST norms. Additionally, valid certifications related to quality assurance protocols must be submitted, alongside the payment of an Earnest Money Deposit (EMD) amounting to ₹17. Eligible participants should have prior experience in supplying pharmaceutical products or medical supplies to government or comparable organizations.
Bidders are required to provide various certificates, including:
The registration process involves applying through the GeM portal. Interested bidders should create an account, provide necessary business documentation, and ensure that all submissions align with the requirements outlined in the tender. Any updates or changes must be reflected in their registered information to enable correct assessment during the evaluation phase.
The accepted document formats include PDF for detailed proposals and Excel for pricing details. Documentation must be clear and organized, ensuring all required information is easily accessible for evaluators. Other related formats may be specified within the tender documentation.
The technical specifications mandate that all pharmaceutical products must comply with Indian Pharmacopoeia standards. Bidders must ensure that the products provided include proper labeling, adhere to specified shelf-life requirements, and comply with storage conditions as recommended by manufacturers and relevant regulatory agencies.
Quality standards must align with established norms set forth by the Indian Pharmacopoeia and other recognized health authority guidelines. This includes specifications for active pharmaceutical ingredients, labeling, and packaging that ensure the integrity and safety of the medical supplies provided.
Bidders must confirm compliance with national regulations and standards governing the supply of pharmaceutical products. This includes adherence to licensing and registration needed for manufacturing and distributing medical supplies, especially those intended for military applications.
The EMD amount for this tender is ₹17. This deposit is essential for showing the seriousness of the bid and should be remitted at the time of bid submission. Refund processes and terms related to EMD will be outlined in the tender documents.
The performance security requirements dictate that bidders may need to submit a performance bond or bank guarantee to ensure contract fulfillment should a bid be accepted. The specifics regarding the amount and duration are detailed within the terms of the tender.
Payment terms typically include stipulations on invoices, timelines for payment post-delivery acceptance, and conditions that may trigger payment delays, such as failures in meeting delivery deadlines or quality standards.
Key timelines include submission deadlines for bids, evaluation periods, and subsequent communication of results to successful bidders. Participants should refer to the tender document for specific details on these critical dates.
The evaluation process will be conducted based on predetermined criteria, emphasizing technical compliance and financial competency. The bid will be evaluated on an item-wise basis, particularly considering bids that come from MSEs and those that align with government procurement policies favoring local vendors.
MSEs are afforded certain advantages in the procurement process, such as expanded eligibility criteria, reduction in performance security amounts, and opportunities for direct participation in government procurement programs, aided by government policy frameworks.
Yes, there are specific provisions for startups aimed at facilitating ease of entry into government procurement channels. These may include relaxed eligibility criteria and consideration for bids from new entrants in the market.
Bidders are encouraged to align their submissions in support of 'Make in India' policies by emphasizing local sourcing, manufacturing, and value addition within India. This is integral to enhancing local industries and reducing dependence on foreign imports.
Compliance with local content requirements involves ensuring that a minimum percentage of the tendered products are manufactured or developed locally. Bidders should confirm adherence to legislation defining local procurement norms as detailed in applicable policy documents.
Border Road Organisation
📍 LEH, JAMMU & KASHMIR
Indian Air Force
📍 JAISALMER, RAJASTHAN
Border Security Force (bsf)
📍 BARMER, RAJASTHAN
Nuclear Power Corporation Of India Limited
📍 SURAT, GUJARAT
Indian Army
📍 SRINAGAR, JAMMU & KASHMIR
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS